To combat America’s declining birth rate, the Trump administration is reportedly considering a $5,000 “baby bonus” for new ...

Johnson & Johnson announced today new data from a Phase 1 study evaluating pasritamig (JNJ-78278343), a first-in-class bispecific antibody that activates T-cells to harness the body's immune system ...